Alan H Auerbach Puma Biotechnology, Inc. (PBYI) insider trading activity

PBYI Quotes by TradingView

Alan H Auerbach is President and CEO of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 7.06 Million shares of PBYI, which is worth approximately $19.1 Million. The most recent transaction as insider was on Jul 17, 2024, when has been sold 21,920 shares (Common Stock) at a price of $3.7 per share, resulting in proceeds of $81,104. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.06M
0% 3M change
1.22% 12M change
Total Value Held $19.1 Million

ALAN H AUERBACH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2024
SELL
Open market or private sale
$81,104 $3.7 p/Share
21,920 Reduced 0.31%
7,063,515 Common Stock
Jul 02 2024
SELL
Open market or private sale
$61,753 $3.27 p/Share
18,885 Reduced 0.27%
7,085,435 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
6,577 Added 0.09%
7,104,320 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
160,796 Added 2.22%
7,097,743 Common Stock
Jan 03 2024
SELL
Open market or private sale
$185,868 $4.49 p/Share
41,396 Reduced 0.59%
6,936,947 Common Stock
Jul 03 2023
SELL
Open market or private sale
$200,910 $3.31 p/Share
60,698 Reduced 0.86%
6,978,343 Common Stock
Feb 10 2023
BUY
Grant, award, or other acquisition
-
186,403 Added 2.58%
7,039,041 Common Stock
Jan 03 2023
SELL
Open market or private sale
$113,867 $4.18 p/Share
27,241 Reduced 0.4%
6,852,638 Common Stock
Dec 12 2022
BUY
Grant, award, or other acquisition
$2,499,996 $4.4 p/Share
568,181 Added 7.63%
6,879,879 Common Stock
Dec 02 2022
SELL
Open market or private sale
$5,629 $4.5 p/Share
1,251 Reduced 0.02%
6,311,698 Common Stock
Nov 02 2022
SELL
Open market or private sale
$2,794 $2.25 p/Share
1,242 Reduced 0.02%
6,312,949 Common Stock
Oct 03 2022
SELL
Open market or private sale
$2,948 $2.34 p/Share
1,260 Reduced 0.02%
6,314,191 Common Stock
Sep 02 2022
SELL
Open market or private sale
$3,248 $2.59 p/Share
1,254 Reduced 0.02%
6,315,451 Common Stock
Aug 02 2022
SELL
Open market or private sale
$3,604 $2.89 p/Share
1,247 Reduced 0.02%
6,316,705 Common Stock
Jul 05 2022
SELL
Open market or private sale
$68,748 $2.63 p/Share
26,140 Reduced 0.41%
6,317,952 Common Stock
Jun 02 2022
SELL
Open market or private sale
$2,328 $1.94 p/Share
1,200 Reduced 0.02%
6,344,092 Common Stock
May 03 2022
SELL
Open market or private sale
$2,930 $2.32 p/Share
1,263 Reduced 0.02%
6,345,292 Common Stock
Apr 04 2022
SELL
Open market or private sale
$3,690 $3.08 p/Share
1,198 Reduced 0.02%
6,346,555 Common Stock
Mar 10 2022
BUY
Grant, award, or other acquisition
$4,999,998 $2.79 p/Share
1,792,114 Added 22.02%
6,347,753 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
168,824 Added 3.57%
4,555,639 Common Stock
Mar 02 2022
SELL
Open market or private sale
$2,924 $2.26 p/Share
1,294 Reduced 0.03%
4,386,815 Common Stock
Feb 02 2022
SELL
Open market or private sale
$3,237 $2.46 p/Share
1,316 Reduced 0.03%
4,388,109 Common Stock
Jan 03 2022
SELL
Open market or private sale
$72,971 $3.19 p/Share
22,875 Reduced 0.52%
4,389,425 Common Stock
Dec 02 2021
SELL
Open market or private sale
$5,327 $2.9 p/Share
1,837 Reduced 0.04%
4,412,300 Common Stock
Nov 02 2021
SELL
Open market or private sale
$10,106 $5.63 p/Share
1,795 Reduced 0.04%
4,414,137 Common Stock
AHA

Alan H Auerbach

President and CEO
Los Angeles, CA

Track Institutional and Insider Activities on PBYI

Follow PUMA BIOTECHNOLOGY, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBYI shares.

Notify only if

Insider Trading

Get notified when an Puma Biotechnology, Inc. insider buys or sells PBYI shares.

Notify only if

News

Receive news related to PUMA BIOTECHNOLOGY, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PBYI